Benzinga | Nov 17, 2021 04:57AM EST

JP Morgan Upgrades Neurocrine Biosciences to Overweight, Announces $124 Price Target

JP Morgan analyst Anupam Rama upgrades Neurocrine Biosciences (NASDAQ:NBIX) from Neutral to Overweight and announces $124 price target.